Clinical trials: Burning Mouth Syndrome
Sleep Disorders, Circadian Rhythm
The Efficacy of Melatonin in the Burning Mouth Syndrome
Burning mouth ( BMS) syndrome is the oral disorder characterized by an intraoral burning sensation for which no medical or dental cause can be found.
- Trial name
- BMS (NCT03788733)
- Testing
- Melatonin 3 mg
- Where
- Spain
- Volunteers
- 80 people, healthy volunteers welcome
- Sponsor
- Universidad de Murcia
Fibromyalgia, Irritable Bowel Syndrome
Efficacy of Transcranial Magnetic Stimulation (TMS) in Chronic Idiopathic Pain Disorders
Objectives : To investigate the analgesic effects of repeated sessions of unilateral rTMS in patients with chronic pain syndrome due to fibromyalgia, IBS or burning mouth syndrome. Primary outcome will be numerical pain scores.
- Conditions
- Fibromyalgia, Irritable Bowel Syndrome, Burning Mouth Syndrome
- Trial name
- NCT00374673
- Testing
- Repetitive transcranial magnetic stimulation
- Where
- France
- Volunteers
- 60 people
- Sponsor
- Hospital Ambroise Paré Paris
Burning Mouth Syndrome, Stomatodynia
Topical Amitriptyline 1% Gel for the Treatment of Burning Mouth Syndrome
Burning mouth syndrome (BMS) is a chronic oral pain condition that causes a persistent burning or stinging sensation in the mouth, often without visible changes in the tissues.
- Trial name
- TOP-AMI → TOPi (NCT07214181)
- Testing
- Topical amitriptyline 1% gel
- Where
- Spain
- Volunteers
- 30 people
- Sponsor
- Universidad de Murcia
Burning Mouth Syndrome
The Efficacy of N-acetyl-cysteine in the Treatment of Burning Mouth Syndrome
The purpose of this study was to examine the efficacy of N-acetyl cysteine in the treatment of burning mouth syndrome. A control group of patients with burning mouth syndrome will receive a placebo.
- Trial name
- NCT05309070
- Testing
- N-acetyl cysteine
- Where
- Croatia
- Volunteers
- 80 people
- Sponsor
- University of Zagreb
Burning Mouth Syndrome
Acupuncture Versus Clonazepam in Burning Mouth Syndrome
Objective: Burning mouth syndrome (BMS) is chronic oral condition characterized with burning symptoms which affects perimenopausal and postmenopausal women. It seems that neuropathy might be the underlying cause of the condition.
- Trial name
- ACUCLONBMS (NCT02382029)
- Testing
- Clonazepam, acupuncture
- Volunteers
- 4 people
- Sponsor
- University of Zagreb
Burning Mouth Syndrome
Inflammatory Markers in Saliva of Patients With Burning Mouth Syndrome
Burning Mouth Syndrome (BMS) is a chronic pain disorder that presents with inflammation and burning sensation in the oral cavity without visible lesions.
- Trial name
- burningmouth (NCT06217731)
- Testing
- Laser+clonazepam, Laser, Clonazepam
- Where
- Spain
- Volunteers
- 20 people
- Sponsor
- Universidad de Murcia
Burning Mouth Syndrome
Impact of Diazepam 1% Oral Gel Efficacy in Burning Mouth Syndrome
Burning mouth syndrome (BMS) is a syndrome characterized by burning and persistent oral pain, ranging from mild to intense, in the absence of organic disorders of the oral cavity and with a major impact on the quality of life of…
- Trial name
- NCT05872789
- Testing
- Diazepam 1% oral gel
- Where
- Italy
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- University of Catania
Burning Mouth Syndrome
Impact of Alpha Lipoic Acid Efficacy in Burning Mouth Syndrome
A double-blind placebo-controlled trial is conducted in order to evaluate the efficacy of alpha lipoic acid (ALA) and determine the statistical significance of the outcome variables.
- Trial name
- NCT05729529
- Testing
- Lipoid acid gel
- Where
- Italy
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- University of Catania
Burning Mouth Syndrome
Comparison of Vortioxetine Versus Other Antidepressants With Pregabalin Augmentation in Burning Mouth Syndrome
Background: The treatment of Burning Mouth Syndrome (BMS) presents a challenge in tailoring appropriate medication for individual patients.
- Trial name
- NCT06025474
- Testing
- Vortioxetine 20Mg Tab, Paroxetine 20 Mg Oral Tablet, Sertraline 50 MG
- Where
- Italy
- Volunteers
- 203 people
- Sponsor
- Federico II University